Comparing FDA Guidance With Reality & Why Real‑World Evidence Still Cannot Stand Alone
- Understanding why best practice RWE guidance does not guarantee acceptance in practice
- Identifying sources of subjectivity and uncertainty in HTA committee decision making
- Designing RWE strategies that improve predictability across markets and bodies